TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
Loftus JC, Dhruv H, Tuncali S, Kloss J, Yang Z, Schumacher CA, Cao B, Williams BO, Eschbacher JM, Ross JT, Tran NL.
Loftus JC, et al.
Mol Cancer Res. 2013 Aug;11(8):865-74. doi: 10.1158/1541-7786.MCR-13-0008. Epub 2013 May 22.
Mol Cancer Res. 2013.
PMID: 23699535
Free PMC article.